1. Home
  2. GPRO vs RFL Comparison

GPRO vs RFL Comparison

Compare GPRO & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoPro Inc.

GPRO

GoPro Inc.

N/A

Current Price

$1.19

Market Cap

119.4M

ML Signal

N/A

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

N/A

Current Price

$1.59

Market Cap

133.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
GPRO
RFL
Founded
2004
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Real Estate
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
119.4M
133.1M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
GPRO
RFL
Price
$1.19
$1.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 15.3M
145.0K
Earning Date
11-05-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 79.08
28.28
EPS
N/A
★ N/A
Revenue
★ $651,542,000.00
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$35.48
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 43.96
52 Week Low
$0.57
$1.12
52 Week High
$2.73
$3.96

Technical Indicators

Market Signals
Indicator
GPRO
RFL
Relative Strength Index (RSI) 47.07 36.99
Support Level $0.68 $1.22
Resistance Level $1.32 $1.58
Average True Range (ATR) 0.07 0.15
MACD -0.03 -0.03
Stochastic Oscillator 4.76 32.63

Price Performance

Historical Comparison
GPRO
RFL

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: